Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus

RG Moore, AK Brown, MC Miller, D Badgwell, Z Lu… - Gynecologic …, 2008 - Elsevier
OBJECTIVE: Tumor markers with increased sensitivity and specificity for endometrial cancer
are needed to help monitor response to therapy and to detect recurrent disease. Currently …
被引用次数：379 相关文章

[引用][C] Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus

RG Moore, AK Brown, MC Miller, D Badgwell… - Gynecologic …, 2008 - cir.nii.ac.jp

Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus

RG Moore, AK Brown, MC Miller… - Gynecologic …, 2008 - pubmed.ncbi.nlm.nih.gov
Objective Tumor markers with increased sensitivity and specificity for endometrial cancer are
needed to help monitor response to therapy and to detect recurrent disease. Currently, the …

Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus

RG Moore, AK Brown, MC Miller, D Badgwell, Z Lu… - Gynecologic …, 2008 - infona.pl
Tumor markers with increased sensitivity and specificity for endometrial cancer are needed
to help monitor response to therapy and to detect recurrent disease. Currently, the tumor …

Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus.

RG Moore, AK Brown, MC Miller, D Badgwell… - Gynecologic …, 2008 - europepmc.org
Objective Tumor markers with increased sensitivity and specificity for endometrial cancer are
needed to help monitor response to therapy and to detect recurrent disease. Currently, the …

Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus

RG Moore, AK Brown, MC Miller… - Gynecologic …, 2008 - mdanderson.elsevierpure.com
Objective: Tumor markers with increased sensitivity and specificity for endometrial cancer
are needed to help monitor response to therapy and to detect recurrent disease. Currently …

Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus

RG Moore, AK Brown, MC Miller… - Gynecologic …, 2008 - gynecologiconcology-online.net
Objective Tumor markers with increased sensitivity and specificity for endometrial cancer are
needed to help monitor response to therapy and to detect recurrent disease. Currently, the …
[HTML] nih.gov

[HTML][HTML] Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus

RG Moore, AK Brown, MC Miller, D Badgwell… - Gynecologic …, 2008 - ncbi.nlm.nih.gov
Objective Tumor markers with increased sensitivity and specificity for endometrial cancer are
needed to help monitor response to therapy and to detect recurrent disease. Currently, the …

[引用][C] Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus

RG MOORE, AK BROWN, MC MILLER… - Gynecologic …, 2008 - Elsevier